GURUFOCUS.COM » STOCK LIST » USA » NYSE » Bristol-Myers Squibb Co (NYSE:BMY) » Definitions » Price-to-Free-Cash-Flow
Switch to:

Bristol-Myers Squibb Co Price-to-Free-Cash-Flow

: 11.13 (As of Today)
View and export this data going back to 1952. Start your Free Trial

As of today (2022-08-07), Bristol-Myers Squibb Co's share price is $72.12. Bristol-Myers Squibb Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $6.48. Hence, Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow Ratio for today is 11.13.

The historical rank and industry rank for Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow or its related term are showing as below:

BMY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.41   Med: 14.24   Max: 375.94
Current: 11.13

During the past 13 years, Bristol-Myers Squibb Co's highest Price-to-Free-Cash-Flow Ratio was 375.94. The lowest was 7.41. And the median was 14.24.

BMY's Price-to-Free-Cash-Flow is ranked better than
73.89% of 475 companies
in the Drug Manufacturers industry
Industry Median: 21.60 vs BMY: 11.13

Bristol-Myers Squibb Co's Free Cash Flow per Share for the three months ended in Jun. 2022 was $0.93. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $6.48.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Bristol-Myers Squibb Co was 25.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 22.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 39.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 11.60% per year.

During the past 13 years, Bristol-Myers Squibb Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 69.60% per year. The lowest was -41.30% per year. And the median was 16.20% per year.


Bristol-Myers Squibb Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.99 13.92 14.90 10.53 9.19

Bristol-Myers Squibb Co Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.94 9.15 9.19 10.71 11.88

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Bristol-Myers Squibb Co Price-to-Free-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow falls into.



Bristol-Myers Squibb Co Price-to-Free-Cash-Flow Calculation

Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=72.12/6.481
=11.13

Bristol-Myers Squibb Co's Share Price of today is $72.12.
Bristol-Myers Squibb Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.48.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Bristol-Myers Squibb Co  (NYSE:BMY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Bristol-Myers Squibb Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Bristol-Myers Squibb Co logo
Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Executives
Greenlees Sharon officer: SVP & Controller BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Shanahan Karin officer: EVP, Glob. Prod. Dev. & Supply BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Meyers Gregory Scott officer: EVP, Chief Digital & Tech Off. BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Weese Michelle officer: EVP, Corporate Affairs BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Hidalgo Medina Manuel director BRISTOL MYERS SQUIBB 430 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016
Rice Derica W director 1000 NICOLLET MALL TPS-3155 MINNEAPOLIS MN 55403
Price Paula A director ONE CVS DRIVE WOONSOCKET RI 02895
Mily Elizabeth officer: EVP, Strategy & BD BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVENCE LINE ROAD PRINCETON NJ 08540
Metcalfe Kathryn officer: EVP, Corporate Affairs BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Vessey Rupert officer: Pres., Research & Early Dev. C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Elkins David V officer: EVP, Chief Financial Officer C/O BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Bonney Michael W director 65 HAYDEN AVE LEXINGTON MA 02421
Yale Phyllis R director
Ahmed Nadim officer: President, Hematology C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Haller Julia A director C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901

Bristol-Myers Squibb Co Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)